Published in the Journal of Clinical Psychiatry, the study involved 31 people aged between 12 and 25 who had been diagnosed with an anxiety disorder. All were given CBD capsules to take daily over twelve weeks.
Published in the journal JAMA Otolaryngology–Head & Neck Surgery, the study used data collected by the National Health and Nutrition Examination Survey (NHANES) to assess the association between cannabis use frequency and reports of sinonasal symptoms.
Analytical Cannabis provides breaks down cannabis distillate, from what it is to how it's made.
High-potency cannabis use is associated with an increased risk of experiencing psychosis and cannabis use disorder (CUD) compared to low-potency products, according to the first systematic review on the topic.
Adolescents who use tobacco e-cigarettes are significantly more likely to report also using cannabis one year later, according to a new study by researchers at the University of Alabama at Birmingham and the University of Michigan.
Dr Stephen Wright, a consultant in medicines development from Limber Strategic, explores the research behind ketamine.
Three cannabis cultivation companies and one testing lab are facing a class action lawsuit in Arkansas. The allegation? That all four conspired to defraud medical cannabis patients by inflating cannabis potency testing results.
Any cannabis lab analyst that has a unique method for identifying and quantifying pesticides in dried cannabis samples has been invited to submit their technique to AOAC International.
As a result of their findings, the Johns Hopkins Medicine researchers say that improvements need to be made to the regulatory oversight of these products in order to ensure good product quality and prevent unwanted drug effects.